HIGH-RISK ARRANGEMENTS IN CONCIERGE PRACTICE — A PRACTICAL FIELD GUIDE

Lab Carve-Out Arrangements

The pattern is familiar and, for that reason, all the more dangerous: a reference laboratory or regional lab system approaches a concierge practice with an offer — free specimen processing equipment, subsidized EHR connectivity, a “medical director” or “scientific advisory” stipend, or testing at rates significantly below what competitors charge. In exchange, the physician routes patient specimens to that laboratory. Even where the practice’s own patients are cash-pay, if those patients are Medicare beneficiaries — or if the physician refers any patients who are — and the laboratory bills Medicare for the testing, the referral relationship is within the AKS’s scope. OIG has brought enforcement actions across a wide range of lab remuneration patterns, and free equipment loans and below-cost testing arrangements are among the most frequently cited. Medical director arrangements tied to labs require particularly careful scrutiny: if the stipend is not commensurate with genuine, documented medical directorship duties, it will be evaluated as remuneration for referrals.

Compounding Pharmacy Relationships

OIG has made compounding pharmacy kickback schemes a sustained enforcement priority, and for good reason: the patterns of abuse are both systematic and financially significant. Arrangements in which compounding pharmacies provide physicians with “consulting fees,” fund continuing medical education events at the practice, supply free patient starter kits or sample preparations, or structure compound pricing at below-cost levels in exchange for directed prescription volume are AKS violations regardless of the physician’s own billing status. The reason is straightforward: compounding pharmacies bill TRICARE, Medicare Part D, and other federal programs for their preparations. The pharmacy’s federal billing provides the nexus. A cash-based internist who receives a $3,000 monthly “advisory fee” from a compounding pharmacy and whose prescriptions account for a material portion of that pharmacy’s TRICARE volume faces meaningful federal exposure even if the physician has never submitted a Medicare claim.

MSO Management Fee Structures

MSO arrangements are foundational to the administrative scalability of many concierge practice models, but they require careful structural analysis. The core risk is that a management fee — particularly one calculated as a percentage of revenue — could be characterized as remuneration that varies with the volume or value of referrals flowing through the practice. This risk is compounded where investor-physicians hold equity in the MSO, where the MSO itself has financial relationships with laboratories, pharmacies, or other referral sources, or where the management fee encompasses marketing services designed to generate patient volume for federally participating providers. Flat-fee structures, clearly scoped service schedules, annually revalidated FMV analyses, and independent legal review of the referral relationship topology within MSO investor groups are the minimum requirements for defensible structuring.

Employer and Direct Contracting Arrangements

The direct employer contracting model is one of the most promising growth avenues for concierge practices, and one of the most legally nuanced. Arrangements with private employers covering only active employees under a commercial self-funded plan generally present limited AKS exposure. But the analysis changes materially when: the employer is a federal contractor or government entity; the employer benefit plan includes a Medicare Advantage component for retired employees; the arrangement is marketed through a benefits consultant or broker who receives a referral fee or commission; or the employer-contracted services include referrals to ancillary providers who bill Medicare. Additionally, marketing payments from employer benefits intermediaries who steer employer clients toward a practice — particularly where those intermediaries also work with Medicare Advantage plans — require careful AKS review.

Physician Cross-Referral Networks

Concierge practices that operate within a network of specialists, imaging centers, ancillary service providers, or complementary health professionals face AKS exposure when financial relationships exist within that network. Shared office space at below-market rates, shared staff arrangements, cross-promotional marketing, and cross-ownership interests between referring and receiving providers are all potential remuneration conduits. An important principle: the AKS analysis for a referral relationship is not eliminated by the fact that the financial relationship appears modest or incidental. OIG’s “one purpose” test means that even a secondary financial benefit — a shared receptionist, a subsidized lease — can implicate the statute if the parties’ relationship is also characterized by referrals of federally reimbursed services.

Sponsored Memberships and Gifted Enrollments

An increasingly common concierge practice model involves employer-sponsored membership, in which an employer pays the practice retainer on behalf of its employees. This arrangement is generally permissible where the employer plan is purely commercial and the population is working-age employees without Medicare coordination. The analysis becomes substantially more complex when the employer’s benefits package includes Medicare Advantage participants, when membership is structured in a manner that effectively steers Medicare beneficiaries toward the practice, or when the sponsoring employer receives any form of discounted or preferred pricing in exchange for the referral of its employee population. Each of these variations requires careful legal analysis before execution.

Conclusion and Key Takeaways

Navigating the regulatory landscape for concierge practices requires careful attention to the nuances of the Anti-Kickback Statute (AKS) and related federal rules. From compounding pharmacy relationships to MSO fee structures, employer contracting, cross-referral networks, and sponsored memberships, each arrangement carries distinct compliance risks that can impact both practices and referring partners. Proactive legal review, transparent structuring, and ongoing fair market value assessments are essential to minimize exposure and ensure defensibility.

• Compounding pharmacy kickback schemes are a major enforcement priority, especially when federal billing is involved.
• MSO management fee structures must avoid remuneration tied to referral volume or value, and require robust legal oversight.
• Employer and direct contracting models present limited AKS risk with private, commercial plans, but risk increases with federal involvement or Medicare Advantage coordination.
• Financial relationships within physician cross-referral networks—even those perceived as minor—can trigger AKS scrutiny when linked to federally reimbursed services.
• Sponsored memberships are generally permissible for commercial populations, but arrangements involving Medicare beneficiaries or discounted pricing demand thorough legal analysis.